Previous Article | Next Article ![]()
Infection and Immunity, December 2000, p. 6819-6825, Vol. 68, No. 12
Department of Medicine and Clinical
Science1 and Department of Cell
Pharmacology, Graduate School of Medicine,2 and
Physiological Chemistry, Faculty of Pharmaceutical
Sciences,3 Kyoto University, Sakyo, Kyoto, and
Physiological Chemistry, Asahikawa Medical University,
Asahikawa,4 Japan
Received 20 December 1999/Returned for modification 9 March
2000/Accepted 1 August 2000
In a previous study we showed that the involvement of EP4 subtype
of the prostaglandin E (PGE) receptor is crucial for lipopolysaccharide (LPS)-induced osteoclast formation in vitro. The present study was
undertaken to test whether EP4 is actually associated with LPS-induced
bone resorption in vivo. In wild-type (WT) mice, osteoclast formation
in vertebrae and tibiae increased 5 days after systemic LPS injection,
and urinary excretion of deoxypyridinoline, a sensitive marker for bone
resorption, statistically increased 10 days after injection. In EP4
knockout (KO) mice, however, LPS injection caused no significant
changes in these parameters throughout the experiment. LPS exposure for
4 h strongly induced osteoclast differentiation factor (ODF) mRNA
expression in primary osteoblastic cells (POB) both from WT and EP4 KO
mice, and this expression was not inhibited by indomethacin, suggesting
prostaglandin (PG) independence. LPS exposure for 24 h further
induced ODF expression in WT POB, but not in EP4 KO POB. Indomethacin
partially inhibited ODF expression in WT POB, but not in EP4 KO POB.
These data suggest that ODF is induced both PG dependently and PG
independently. LPS exposure for 24 h induced slightly greater
osteoclastgenesis inhibitory factor (OCIF) mRNA expression in EP4 KO
than in WT POB. These findings suggest that the reduced ODF expression
and apparently increased OCIF expression also are responsible for the
markedly reduced LPS-induced osteoclast formation in EP4 KO mice. Our
results show that the EP4 subtype of the PGE receptor is involved in
LPS-induced bone resorption in vivo also. Since LPS is considered to be
largely involved in bacterially induced bone loss, such as in
periodontitis and osteomyelitis, our study is expected to help broaden
our understanding of the pathophysiology of these conditions.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Impaired Bone Resorption by Lipopolysaccharide In
Vivo in Mice Deficient in the Prostaglandin E Receptor EP4
Subtype
*
Corresponding author. Mailing address: Department of
Medicine and Clinical Science, Graduate School of Medicine, Kyoto
University, 54, Shogoin-kawaharacho, Sakyo, Kyoto 606-8507, Japan.
Phone: 81-75-753-7509. Fax: 81-75-771-9452. E-mail:
ktanaka{at}koshien.ac.jp.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»